SCHEMBL18502965

SCHEMBL18502965

COc1c(Cl)ccc(/C=N\O)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KMT2A Q03164 1/20 0.44
MEP1B Q16820 1/20 0.41
ALDH1A1 P00352 6/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
PKM P14618 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 3/20 0.36
HTT P42858 3/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35
GAA P10253 2/20 0.34
MAPT P10636 1/20 0.33
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18508561 1.00 KDM4E (0.44) KDM4EL3MBTL1KMT2AMEP1BALDH1A1
SCHEMBL18502977 0.83 L3MBTL1 (0.36) KDM4EL3MBTL1KMT2AALDH1A1HPGD
SCHEMBL18508550 0.83 HPGD (0.49) KDM4EL3MBTL1KMT2AALDH1A1CYP1A2
SCHEMBL18508480 0.83 L3MBTL1 (0.36) KDM4EL3MBTL1KMT2AALDH1A1HPGD
SCHEMBL18502973 0.83 HPGD (0.49) KDM4EL3MBTL1KMT2AALDH1A1CYP1A2
SCHEMBL20150852 0.81 L3MBTL1 (0.39) KDM4EL3MBTL1KMT2AALDH1A1CYP1A2
SCHEMBL20148177 0.81 L3MBTL1 (0.39) KDM4EL3MBTL1KMT2AALDH1A1CYP1A2
SCHEMBL6443594 0.79 KDM4E (0.43) KDM4EL3MBTL1KMT2AALDH1A1CYP1A2
SCHEMBL18502957 0.78 L3MBTL1 (0.37) KDM4EL3MBTL1KMT2AALDH1A1CYP1A2
SCHEMBL18508494 0.78 L3MBTL1 (0.37) KDM4EL3MBTL1KMT2AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2018-05-17 US disclosed
US-20170044155-A1 Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors AXOVANT SCIENCES GMBH (CH) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044155-A1 Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA6 KDM4E 3493/4885L3MBTL1 3087/4885KMT2A 2115/4885
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA2 KDM4E 3741/4885L3MBTL1 3492/4885KMT2A 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.